Saphenous vein remains a widely used conduit in coronary surgery. However, the long-term success of surgical myocardial revascularization is largely limited by the development of neointimal hyperplasia and superimposed atherosclerosis in vein grafts. Although strategies for preventing vein graft failure have been constantly explored, few therapeutic interventions to date have shown sustained benefits in the clinical setting. The application of external support has emerged as a promising strategy for modulating the overall biomechanical responses in venous wall. Nonetheless, clinical translation of this intervention has been formerly challenged, primarily due to several technique limitations. The purpose of the current review is to summarize the possible mechanisms involved in the external support strategy for preventing vein graft failure. Furthermore, several previously tested biomaterials and delivery techniques are also highlighted.
KappeteinAPFeldmanTEMackMJMoriceMCHolmesDRStåhleE. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J2011; 32: 2125–2134.
2.
WanSGeorgeSJBerryCBakerAH. Vein graft failure: current clinical practice and potential for gene therapeutics. Gene Ther2012; 19: 630–636.
GeorgeSJWanSHuJJohnsonJLMacDonaldRBakerAH. Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy. Circulation2011; 124: S135–S142.
5.
KangNNgCSHuJQiuZBUnderwoodMJJeremyJYWanS. Role of osteopontin in the development of neointimal hyperplasia in vein grafts. Eur J Cardiothorac Surg2012; 41: 1384–1389.
6.
MehtaDGeorgeSJJeremyJYIzzatMBSouthgateKMBryanAJ. External stenting reduces long-term medial and intimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting. Nat Med1998; 4: 235–239.
7.
JeremyJYGadsdonPShuklaNVijayanVWyattMNewbyAC. On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents. Biomaterials2007; 28: 895–908.
8.
DesaiMMirzay-RazzazJvon DelftDSarkarSHamiltonGSeifalianAM. Inhibition of intimal formation and hyperplasia in vein grafts by external stent/sheath. Vasc Med2010; 15: 287–297.
9.
MurphyGJNewbyACJeremyJYBaumbachAAngeliniGD. A randomized trial of an external Dacron sheath for the prevention of vein graft disease: the Extent study. J Thorac Cardiovasc Surg2007; 134: 504–505.
10.
SchoettlerJJussli-MelchersJGrothusenCStrackeLSchoeneichFStohnS. Highly flexible nitinol mesh to encase aortocoronary saphenous vein grafts: first clinical experiences and angiographic results nine months postoperatively. Interact Cardiovasc Thorac Surg2011; 13: 396–400.
11.
ParsonnetVLariAAShahIH. New stent for support of veins in arterial grafts. Arch Surg1963; 87: 696–702.
12.
BarraJAVolantALeroyJPBraescoJAiriauJBoschatJ. Constrictive perivenous mesh prosthesis for preservation of vein integrity. Experimental results and application for coronary bypass grafting. J Thorac Cardiovasc Surg1986; 92: 330–336.
13.
OwensCD. Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications. J Vasc Surg2010; 51: 736–746.
14.
ChengJWangYMaYChanBTYangMLiangA. The mechanical stress-activated serum-, glucocorticoid-regulated kinase 1 contributes to neointima formation in vein grafts. Circ Res2010; 107: 1265–1274.
15.
El-KurdiMSHongYStankusJJSolettiLWagnerWRVorpDA. Transient elastic support for vein grafts using a constricting microfibrillar polymer wrap. Biomaterials2008; 29: 3212–3220.
HumanPFranzTSchermanJMoodleyLZillaP. Dimensional analysis of human saphenous vein grafts: Implications for external mesh support. J Thorac Cardiovasc Surg2009; 137: 1101–1108.
18.
ZillaPWolfMRafieeNMoodleyLBezuidenhoutDBlackM. Utilization of shape memory in external vein-graft meshes allows extreme diameter constriction for suppressing intimal hyperplasia: a nonhuman primate study. J Vasc Surg2009; 49: 1532–1542.
19.
VijayanVShuklaNJohnsonJLGadsdonPAngeliniGDSmithFC. A long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath. J Vasc Surg2004; 40: 1011–1019.
20.
GeorgeSJIzzatMBGadsdonPJohnsonJLYimAPWanS. Macro-porosity is necessary for the reduction of intimal and medial thickening by external stenting of porcine saphenous vein bypass grafts. Atherosclerosis2001; 155: 329–336.
JeremyJYDashwoodMRMehtaDIzzatMBShuklaNAngeliniGD. Nitric oxide, prostacyclin and cyclic nucleotide formation in externally stented porcine vein grafts. Atherosclerosis1998; 141: 297–305.
23.
AngeliniGDLloydCBushRJohnsonJNewbyAC. An external, oversized, porous polyester stent reduces vein graft neointima formation, cholesterol concentration, and vascular cell adhesion molecule 1 expression in cholesterol-fed pigs. J Thorac Cardiovasc Surg2002; 124: 950–956.
24.
LardenoyeJHDe VriesMRGrimbergenJMHavekesLMKnaapenMWKockxMM. Inhibition of accelerated atherosclerosis in vein grafts by placement of an external stent in ApoE*3-Leiden transgenic mice. Arterioscler Thromb Vasc Biol2002; 22: 1433–1438.
25.
DashwoodMRGibbinsRMehtaDBashar IzzatMAngeliniGDJeremyJY. Neural reorganisation in porcine vein grafts: a potential role for endothelin-1. Atherosclerosis2000; 150: 43–53.
26.
DashwoodMRLoeschA. The saphenous vein as a bypass conduit: the potential role of vascular nerves in graft performance [Review]. Curr Vasc Pharmacol2009; 7: 47–57.
27.
DashwoodMRAngeliniGDWanSYimAMehtaDIzzatMB. Does external stenting reduce porcine vein-graft occlusion via an action on vascular nerves?J Card Surg2002; 17: 556–560.
28.
ZurbrüggHRHetzerR. The use of biocompound-grafts together with varicose veins. First clinical experience. J Cardiovasc Surg1996; 37: 143–146.
29.
ZurbrüggHRKnollmannFMusciMWiedMBauerMChavezT. The biocompound method in coronary artery bypass operations: surgical technique and 3-year patency. Ann Thorac Surg2000; 70: 1536–1540.
30.
RescignoGAngeliniAD'AlfonsoATorraccaL. Coronary graft use of a new external mesh support. Interact Cardiovasc Thorac Surg2010; 10: 645–647.
31.
IzzatMBMehtaDBryanAJReevesBNewbyACAngeliniGD. Influence of external stent size on early medial and intimal thickening in a pig model of saphenous vein bypass grafting. Circulation1996; 94: 1741–1745.
32.
YouQDuanLWangFDuXXiaoM. Characterization of the inhibition of vein graft intimal hyperplasia by a biodegradable vascular stent. Cell Biochem Biophys2011; 59: 99–107.
33.
FranzTHumanPDobnerSReddyBDBlackMIlsleyH. Tailored sizes of constrictive external vein meshes for coronary artery bypass surgery. Biomaterials2010; 31: 9301–9309.
34.
ZillaPMoodleyLWolfMFBezuidenhoutDSirryMSRafieeN. Knitted nitinol represents a new generation of constrictive external vein graft meshes. J Vasc Surg2011; 54: 1439–1450.
35.
van der MerweHDaya ReddyBZillaPBezuidenhoutDFranzT. A computational study of knitted Nitinol meshes for their prospective use as external vein reinforcement. J Biomech2008; 41: 1302–1309.
36.
LiaoSWLuXPutnamAJKassabGS. A novel time-varying poly lactic-coglycolic acid external sheath for vein grafts designed under physiological loading. Tissue Eng2007; 13: 2855–2862.
37.
SkalskyIFilovaESzarszoiOParizekMLytvynetsAMaluskovaJ. A periadventitial sirolimus-releasing mesh decreased intimal hyperplasia in a rabbit model. Physiol Res2011; 60: 585–588.
38.
KhuranaRZhuangZBhardwajSMurakamiMDe MuinckEYla-HerttualaS. Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation2004; 110: 2436–2443.
39.
WanSArifiAAChanMCYipJHNgCSChowLT. Differential, time-dependent effects of perivenous application of fibrin glue on medial thickening in porcine saphenous vein grafts. Eur J Cardiothorac Surg2006; 29: 742–746.
